K
Kaiu Prikk
Researcher at Tallinn University of Technology
Publications - 6
Citations - 224
Kaiu Prikk is an academic researcher from Tallinn University of Technology. The author has contributed to research in topics: COPD & Translational medicine. The author has an hindex of 5, co-authored 6 publications receiving 183 citations.
Papers
More filters
Journal ArticleDOI
Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial
Paul Walker,Pasquale P. Pompilio,Paolo Zanaboni,Trine S Bergmo,Kaiu Prikk,Andrei Malinovschi,Josep M. Montserrat,Jo Middlemass,Silvana Šonc,Giulia Munaro,Dorjan Marušič,Ruth Sepper,Roberto Rosso,A Niroshan Siriwardena,Christer Janson,Ramon Farré,Peter M.A. Calverley,Raffaele Dellaca +17 more
TL;DR: In older patients with COPD and comorbidities, remote monitoring of lung function by forced oscillation technique and cardiac parameters did not change TTFH and EQ‐5D and an exploratory analysis found telemedicine was associated with fewer repeat hospitalizations.
Journal ArticleDOI
Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging.
Thomas E. Fehniger,Ákos Végvári,Melinda Rezeli,Kaiu Prikk,Peeter Ross,Magnus Dahlbäck,Goutham Edula,Ruth Sepper,György Marko-Varga,György Marko-Varga +9 more
TL;DR: This is the first reported study in applying MALDI-MSI to demonstrate the localization of a drug administered at therapeutic levels, and it is demonstrated that ipratropium is rapidly absorbed into the airway wall.
Journal ArticleDOI
Lung dysfunction of chronic smokers with no signs of COPD.
TL;DR: It is concluded that lung function deviation and lung structural changes are present in CSs before the clinical signs of airway obstruction reveal, and body plethysmography and diffusing capacity measurement with routine spirometry can provide valuable information for detection of changes reflecting to the early onset of COPD.
Journal ArticleDOI
Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine.
György Marko-Varga,György Marko-Varga,Ákos Végvári,Melinda Rezeli,Kaiu Prikk,Peeter Ross,Magnus Dahlbäck,Goutham Edula,Ruth Sepper,Thomas E. Fehniger,Thomas E. Fehniger +10 more
TL;DR: It is demonstrated that robust imaging data could be generated confirming drug localization in pulmonary regions of COPD patients with tumor pathology, and bridging comprehension that forms a knowledge base that can be used by society to develop a better treatment and medicine for patients.
Journal ArticleDOI
Mucin5B expression by lung alveolar macrophages is increased in long-term smokers.
Ruth Sepper,Kaiu Prikk,Madis Metsis,Svetlana Sergejeva,Natalia Pugatsjova,Olga Bragina,Sirje Marran,Thomas E. Fehniger +7 more
TL;DR: M UC5B is expressed in a subset of lung AMs and long‐term cigarette smoking may increase the level of MUC5B produced by these cells.